ask="N/A"
ask_size="N/A"
average_daily_volume="56300"
bid="14.00"
bid_size="1000"
book_value="6.38"
change="-0.02"
change_from_200_day_moving_average="-1.45"
change_from_50_day_moving_average="-0.80"
change_from_52_week_high="-5.65"
change_From_52_week_low="2.03"
change_in_percent="-0.13%"
close="15.09"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.72"
ebitda="-48.18M"
eps_estimate_current_year="-4.11"
eps_estimate_next_quarter="-0.68"
eps_estimate_next_year="-3.46"
ex_dividend_date="N/A"
float_shares="9110000"
high="15.48"
high_52_weeks="20.74"
last_trade_date="3/8/2017"
last_trade_price="15.09"
last_trade_size="2091"
last_trade_time="4:00pm"
low="15.01"
low_52_weeks="13.06"
market_capitalization="327.83M"
moving_average_200_day="16.54"
moving_average_50_day="15.89"
name="Audentes Therapeutics
Inc."
notes="N/A"
one_year_target_price="22.33"
open="15.26"
pe_ratio="N/A"
peg_ratio="-1.43"
percent_change_from_200_day_moving_average="-8.79%"
percent_change_from_50_day_moving_average="-5.06%"
percent_change_from_52_week_high="-27.24%"
percent_change_from_52_week_low="+15.54%"
previous_close="15.11"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.37"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21725000"
short_ratio="19.40"
stock_exchange="NGM"
symbol="BOLD"
volume="13732"
weeks_range_52="13.06 - 20.74"
